Jamieson Wellness (TSE:JWEL – Get Free Report) had its target price upped by stock analysts at National Bankshares from C$36.50 to C$42.00 in a note issued to investors on Monday,BayStreet.CA reports. National Bankshares’ price objective would suggest a potential upside of 15.19% from the company’s previous close.
Several other equities research analysts also recently weighed in on JWEL. TD Securities upped their price target on Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Canaccord Genuity Group upped their price target on Jamieson Wellness from C$32.50 to C$36.25 in a report on Friday, August 9th. Royal Bank of Canada upped their price target on Jamieson Wellness from C$37.00 to C$38.00 in a report on Friday, November 8th. Finally, BMO Capital Markets upped their price target on Jamieson Wellness from C$35.00 to C$42.00 in a report on Friday, August 9th.
Read Our Latest Stock Analysis on Jamieson Wellness
Jamieson Wellness Price Performance
Insiders Place Their Bets
In other news, Senior Officer Regan Stewart sold 6,300 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of C$35.69, for a total transaction of C$224,847.00. Also, Director Michael Al Pilato sold 24,465 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of C$33.41, for a total value of C$817,380.54. In the last ninety days, insiders sold 32,402 shares of company stock valued at $1,100,612. 0.26% of the stock is owned by company insiders.
About Jamieson Wellness
Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.
See Also
- Five stocks we like better than Jamieson Wellness
- Consumer Discretionary Stocks Explained
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Trading Halts Explained
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.